Most head and neck cancers are derived from the mucosal epithelium in the oral cavity,
pharynx and larynx and are known collectively as head and neck squamous cell carcinoma (…

… neck squamous cell carcinoma patients in large systematic reviews. The average smoker
requires over 10 attempts to discontinue, though this figure can be dramatically reduced by a …

… All patients presenting with neck squamous cell carcinoma … of head and neck squamous
cell carcinoma is associated with … sites in patients initially presenting with neck squamous cell …

… outcomes of patients with ESmCCs of the head and neck. … of 21 patients with ESmCCs of
the head and neck who were … patients were diagnosed with ESmCCs of the head and neck …

… evidence-based recommendations to practicing physicians and others on the management
of the neck in patients with squamous cell carcinoma of the oral cavity and oropharynx. …

… 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance
vs CRT in patients with locally advanced squamous cell carcinoma of the head and …

… A study in 49 oropharyngeal squamous cell carcinoma patients with a palpably negative
neck showed that the addition of PET-CT to CT/MRI did not provide better diagnostic accuracy …

… Treating head and neck cancer patients with systemic therapy is challenging because of …
Patients with locally advanced or recurrent/metastatic head and neck squamous cell carcinoma (…

… literature on cSCC that is not specific to the head and neck region [21, 51]. Based on these …
and neck patients that could possibly benefit from a SLNB (Table 3). We believe that a patient …

… To determine the effectiveness and outcomes of SND in the treatment of patients with
squamous cell carcinoma of the head and neck (SCCHN) with clinically positive neck (cN+) at …